RPSA
DGX icon

Richard P. Slaughter Associates’s Quest Diagnostics DGX Stock Holding History

Richard P. Slaughter Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,540
Closed -$2.97M – 123
2021
Q2 		$2.97M Buy
22,540
+131
+0.6% +$17.2K 1.15% 25
2021
Q1 		$2.88M Buy
22,409
+443
+2% +$54.6K 1.19% 26
2020
Q4 		$2.62M Sell
21,966
-348
-2% -$42.4K 1.11% 27
2020
Q3 		$2.55M Buy
+22,314
New +$2.64M 1.17% 24

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Richard P. Slaughter Associates's DGX Position: Q3 2021 in Review

Richard P. Slaughter Associates sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 22,540 shares — an estimated $2.97M sold.

Richard P. Slaughter Associates first reported a position in DGX in Q3 2020 and held it in 4 quarters. The position peaked at $2.97M in Q2 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Richard P. Slaughter Associates reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Richard P. Slaughter Associates sold 22,540 Quest Diagnostics shares in Q3 2021, an estimated $2.97M.
  • Richard P. Slaughter Associates first reported a position in Quest Diagnostics in Q3 2020 and held it in 4 quarters.
  • Richard P. Slaughter Associates's Quest Diagnostics position peaked at $2.97M in Q2 2021.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Richard P. Slaughter Associates's 13F filing for Q3 2021, filed 6 Oct 2021.